Table 3.
Neurotransmitter | Approx. extracellular concentration | Brain region |
---|---|---|
Glutamate | 1 μM[7], 1.4 μM[13] | striatum |
γ-aminobutyric acid | 0.2 μM[7], 0.17 μM[13] | striatum |
Glycine | 1.6 μM[7], 6 μM[13] | striatum |
Aspartate | 0.3 μM[7] | striatum |
Taurine | 26 μM[13] | striatum |
L-Serine, D-Serine | 28 μM[13], 15 μM[13] | striatum |
Dopamine | 26 nM,[74] 40 nM[75] | nucleus accumbens, striatum |
Dorepinephrine | 12 nM[76] | striatum |
Epinephrine | ~ 10% of NE[77] | Not reported |
Serotonin | 70 nM[75], 68 nM[76] | striatum |
Met-enkephalin | 127 ± 16 pM[78], 110, 50 pM[79] | striatum |
Leu-enkephalin | 51 ± 9 pM[78], 36, 23 pM[79] | striatum |
Dynorphin | 78 ± 7 pM[78] | striatum |
β-endorphin | 109 ± 7 pM[78] | striatum |
Endomorphin 2 | 1259 ± 297 pM[80] | spinal cord |
Vasopressin | ~ 25 pM[81] | anterior pituitary |
Corticotrophin releasing hormone | ~ 25–40 pM[81] | anterior pituitary |
Growth hormone releasing hormone | 40 pg/mL[82, 83] ~ 8 pM | hypothalamus (cattle) |
Somatostatin | 333 ± 8 pM[84] | striatum |
Substance P | 23.5 pM[85] | CSF (human) |
Neurokinin α | 2.31/2.24 nM[86] | CSF (human) |
Neuropeptide tyrosin | 26.1 ± 3.5 pM[87] | ventral stiatum |
Vasoactive intestinal polypeptide | 25.5 ± 7.5 pmol per gram of tissue[88] | cerebral cortex tissue |
Neurotensin | 49.7 ± 7.0 pM[87] | ventral stiatum |
Nociceptin/orphanin FQ | 63 ± 12 pM/60 ± 8 pM [89] | hippocampus/thalamus |
Cholecystokinin | 2.3 ± 0.1 pM[90] | anterior cingulated cortex |
Galanin | 7.9 pM[91] | spinal cord |
Hypocretins/orexins | ~ 60 pM (BF) ~ 75 pM (HYP) ~ 45 pM (LC) [92] |
basal forebrain, perifornical hypothalamus, and locus ceruleus |
Angiotensin | 46 pM [93] | globus pallidus/ventral pallidum |
Acetylcholine | 0.4–4 nM,[94] 2.8 μM[95] | hippocampus, prefrontal cortex |
Adenosine triphophosphate | 0.5–10 μM[96] | dorsal spinal horn (frog) |
Adenosine | 200 nM[97] | Not reported |
Nitric oxide | 92 nM[98] | striatum |